Coronary calcification is associated with lower bone formation rate in CKD patients not yet in dialysis treatment

Journal of Bone and Mineral Research

Volumn 25, Issue 3, 2010, Pages 499-504

  Tomiyama, Cristianne ^a   Carvalho, Aluizio B ^a   Higa, Andrea ^a   Jorgetti, Vanda ^b   Draibe, Sérgio A ^a   Canziani, Maria Eugênia F ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Bone mineral metabolism; Bone formation rate; Chronic kidney disease; Coronary calcification; Predialysis

Indexed keywords

ADULT; ARTERY CALCIFICATION; ARTICLE; BLOOD VESSEL CALCIFICATION; CARDIOVASCULAR DISEASE; CHRONIC KIDNEY DISEASE; DIABETES MELLITUS; DIALYSIS; DISEASE ASSOCIATION; FEMALE; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; OSSIFICATION; OSTEOCLAST; POPULATION; PREVALENCE; RISK FACTOR; SCORING SYSTEM; SEX; SURFACE PROPERTY; TRABECULAR BONE; BONE; BONE DEVELOPMENT; CALCINOSIS; COMPLICATION; CORONARY ARTERY DISEASE; DISEASE COURSE; METABOLISM; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; REGRESSION ANALYSIS; RENAL INSUFFICIENCY, CHRONIC; RENAL REPLACEMENT THERAPY;

BONE AND BONES; CALCINOSIS; CORONARY ARTERY DISEASE; DISEASE PROGRESSION; FEMALE; HUMANS; MALE; MIDDLE AGED; OSTEOGENESIS; REGRESSION ANALYSIS; RENAL DIALYSIS; RENAL INSUFFICIENCY, CHRONIC; RISK FACTORS;

EID: 77953448102     PISSN: 08840431     EISSN: None     Source Type: Journal    
DOI: 10.1359/jbmr.090735     Document Type: Article

References (50)

1. Elhajj II, Haydar AA, Hujairi NM, Goldsmith DJ. The role of inflammation in acute coronary syndromes: review of the literature. J Med Liban. 2004;52:96-102. (Pubitemid 40675840)
2. Kramer H, Toto R, Peshock R, Cooper R, Victor R. Association between chronic kidney disease and coronary artery calcification: the Dallas Heart Study. J Am Soc Nephrol. 2005;16:507-513. (Pubitemid 41725148)
3. London GM, Guerin AP, Marchais SJ, Metivier F, Pannier B, Adda H. Arterial media calcification in end-stage renal disease: impact on all-cause and cardiovascular mortality. Nephrol Dial Transplant. 2003;18: 1731-1740. (Pubitemid 37098542)
4. Block GA, Raggi P, Bellasi A, Kooienga L, Spiegel DM. Mortality effect of coronary calcification and phosphate binder choice in incident hemodialysis patients. Kidney Int. 2007;71:438-441. (Pubitemid 46303553)
5. Mehrotra R. Disordered mineral metabolism and vascular calcification in nondialyzed chronic kidney disease patients. J Ren Nutr. 2006;16:100-118.
6. Shanahan CM, Cary NR, Salisbury JR, et al. Medial localization of mineralization-regulating proteins in association with Monckeberg's sclerosis: evidence for smooth muscle cell-mediated vascular calcification. Circulation. 1999;100:2168-2176.
7. Goodman WG, Goldin J, Kuizon BD, et al. Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis. N Engl J Med. 2000;342:1478-1483. (Pubitemid 30318271)
8. Wang AY, Wang M, Woo J, et al. Cardiac valve calcification as an important predictor for all-cause mortality and cardiovascular mortality in long-term peritoneal dialysis patients: a prospective study. J Am Soc Nephrol. 2003;14:159-168. (Pubitemid 36032720)
9. Haydar AA, Covic A, Colhoun H, Rubens M, Goldsmith DJ. Coronary artery calcification and aortic pulse wave velocity in chronic kidney disease patients. Kidney Int. 2004;65:1790-1794. (Pubitemid 38591027)
10. Barreto DV, Barreto FC, Carvalho AB, et al. Coronary calcification in hemodialysis patients: the contribution of traditional and uremia-related risk factors. Kidney Int. 2005;67:1576-1582. (Pubitemid 40463138)
11. Russo D, Palmiero G, De Blasio AP, Balletta MM, Andreucci VE. Coronary artery calcification in patients with CRF not undergoing dialysis. Am J Kidney Dis. 2004;44:1024-1030. (Pubitemid 39556482)
12. Tomiyama C, Higa A, Dalboni MA, et al. The impact of traditional and nontraditional risk factors on coronary calcification in pre-dialysis patients. Nephrol Dial Transplant. 2006;21:2464-2471. (Pubitemid 44644518)
13. Porter CJ, Stavroulopoulos A, Roe SD, Pointon K, Cassidy MJ. Detection of coronary and peripheral artery calcification in patients with chronic kidney disease stages 3 and 4, with and without diabetes. Nephrol Dial Transplant. 2007;22:3208-3213. (Pubitemid 350202554)
14. K/DOQI. clinical practice guidelines for bone metabolism and disease in chronic kidney disease. Am J Kidney Dis. 2003;42:S1-201.
15. Agatston AS, Janowitz WR, Hildner FJ, Zusmer NR, Viamonte M Jr, Detrano R. Quantification of coronary artery calcium using ultrafast computed tomography. J Am Coll Cardiol. 1990;15:827-832. (Pubitemid 20101575)
16. Parfitt AM, Drezner MK, Glorieux FH, et al. Bone histomorphometry: standardization of nomenclature, symbols, and units. Report of the ASBMR Histomorphometry Nomenclature Committee. J Bone Miner Res. 1987;2:595-610.
17. Dos Reis LM, Batalha JR, Munoz DR, et al. Brazilian normal static bone histomorphometry: effects of age, sex, and race. J Bone Miner Metab. 2007;25:400-406.
18. Melsen F, Mosekilde L. Tetracycline double-labeling of iliac trabecular bone in 41 normal adults. Calcif Tissue Res. 1978;26:99-102.
19. K/DOQI. clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis. 2002;39:S1-266.
20. Raggi P, Boulay A, Chasan-Taber S, et al. Cardiac calcification in adult hemodialysis patients: a link between end-stage renal disease and cardiovascular disease? J Am Coll Cardiol. 2002;39:695-701.
21. Stompor T, Pasowicz M, Sullowicz W, et al. An association between coronary artery calcification score, lipid profile, and selected markers of chronic inflammation in ESRD patients treated with peritoneal dialysis. Am J Kidney Dis. 2003;41:203-211. (Pubitemid 36043368)
22. Barreto DV, Barreto FdC, Carvalho ABd, et al. Association of changes in bone remodeling and coronary calcification in hemodialysis patients: a prospective study. Am J Kidney Dis. 2008: (in press).
23. London GM, Marty C, Marchais SJ, Guerin AP, Metivier F, de Vernejoul MC. Arterial calcifications and bone histomorphometry in end-stage renal disease. J Am Soc Nephrol. 2004;15:1943-1951. (Pubitemid 38822076)
24. F.L,J.B, Renal osteodystrophies. In: BM B, ed. The Kidney. Philadelphia: Saunders; 2000; 2103-2186.
25. Solal ME, Sebert JL, Boudailliez B, et al. Comparison of intact, midregion, and carboxy-terminal assays of parathyroid hormone for the diagnosis of bone disease in hemodialyzed patients. J Clin Endocrinol Metab. 1991;73:516-524. (Pubitemid 21921903)
26. Coen G, Ballanti P, Bonucci E, et al. Renal osteodystrophy in predialysis and hemodialysis patients: comparison of histologic patterns and diagnostic predictivity of intact PTH. Nephron. 2002; 91:103-111. (Pubitemid 34522839)
27. Sherrard DJ, Hercz G, Pei Y, et al. The spectrum of bone disease in end-stage renal failure: an evolving disorder. Kidney Int. 1993;43: 436-442. (Pubitemid 23162839)
28. Ingham JP, Stewart JH, Posen S. Quantitative skeletal histology in untreated end-stage renal failure. Br Med J. 1973;2:745-748.
29. Hutchison AJ, Whitehouse RW, Boulton HF, et al. Correlation of bone histology with parathyroid hormone, vitamin D3, and radiology in end-stage renal disease. Kidney Int. 1993;44:1071-1077.
30. Hernandez D, Concepcion MT, Lorenzo V, et al. Adynamic bone disease with negative aluminium staining in predialysis patients: prevalence and evolution after maintenance dialysis. Nephrol Dial Transplant. 1994;9:517-523. (Pubitemid 24159978)
31. Spasovski GB, Bervoets AR, Behets GJ, et al. Spectrum of renal bone disease in end-stage renal failure patients not yet on dialysis. Nephrol Dial Transplant. 2003;18:1159-1166.
32. Yano S, Yamaguchi T, Kanazawa I, et al. The uraemic toxin phenylacetic acid inhibits osteoblastic proliferation and differentiation: an implication for the pathogenesis of low turnover bone in chronic renal failure. Nephrol Dial Transplant. 2007;22:3160-3165. (Pubitemid 350202573)
33. Picton ML, Moore PR, Mawer EB, et al. Downregulation of human osteoblast PTH/PTHrP receptor mRNA in end-stage renal failure. Kidney Int. 2000;58:1440-1449.
34. Slatopolsky E, Finch J, Clay P, et al. A novel mechanism for skeletal resistance in uremia. Kidney Int. 2000;58:753-761. (Pubitemid 30620025)
35. Quarles LD, Lobaugh B, Murphy G. Intact parathyroid hormone overestimates the presence and severity of parathyroid-mediated osseous abnormalities in uremia. J Clin Endocrinol Metab. 1992;75: 145-150.
36. Davies MR, Lund RJ, Mathew S, Hruska KA. Low-turnover osteodystrophy and vascular calcification are amenable to skeletal anabolism in an animal model of chronic kidney disease and the metabolic syndrome. J Am Soc Nephrol. 2005;16:917-928. (Pubitemid 41710302)
37. Tsujikawa H, Kurotaki Y, Fujimori T, Fukuda K, Nabeshima Y. Klotho, a gene related to a syndrome resembling human premature aging, functions in a negative regulatory circuit of vitamin D endocrine system. Mol Endocrinol. 2003;17:2393-2403. (Pubitemid 37542205)
38. Wang H, Yoshiko Y, Yamamoto R, et al. Overexpression of fibroblast growth factor 23 suppresses osteoblast differentiation and matrix mineralization in vitro. J Bone Miner Res. 2008;23:939-948. (Pubitemid 351768812)
39. Shimada T, Kakitani M, Yamazaki Y, et al. Targeted ablation of FGF23 demonstrates an essential physiological role of FGF 23 in phosphate and vitamin D metabolism. J Clin Invest. 2004;113:561-568. (Pubitemid 38542505)
40. Jehle PM, Ostertag A, Schulten K, et al. Insulin-like growth factor system components in hyperparathyroidism and renal osteodystrophy. Kidney Int. 2000;57:423-436. (Pubitemid 30430634)
41. Wang S, Chen Q, Simon TC, et al. Bone morphogenic protein 7 (BMP-7), a novel therapy for diabetic nephropathy1. Kidney Int. 2003;63: 2037-2049. (Pubitemid 36605815)
42. Andress DL, Pandian MR, Endres DB, Kopp JB. Plasma insulin-like growth factors and bone formation in uremic hyperparathyroidism. Kidney Int. 1989;36:471-477. (Pubitemid 19209127)
43. Jena N, Martin-Seisdedos C, McCue P, Croce CM. BMP7-null mutation in mice: developmental defects in skeleton, kidney, and eye. Exp Cell Res. 1997;230:28-37. (Pubitemid 27187536)
44. Kiel DP, Kauppila LI, Cupples LA, Hannan MT, O'Donnell CJ, Wilson PW. Bone loss and the progression of abdominal aortic calcification over a 25year period: the Framingham Heart Study. Calcif Tissue Int. 2001;68:271-276.
45. Hak AE, Pols HA, van Hemert AM, Hofman A, Witteman JC. Progression of aortic calcification is associated with metacarpal bone loss during menopause: a population-based longitudinal study. Arterioscler Thromb Vasc Biol. 2000;20:1926-1931. (Pubitemid 30644642)
46. Frost M, Grella R, Millasseau S, et al. Relationship of calcification of atherosclerotic plaque and arterial stiffness to bone mineral density and osteoprotegerin in postmenopausal women referred for osteoporosis screening. Calcif Tissue Int. 2008: (in press).
47. Hsia J, Klouj A, Prasad A, Burt J, Adams-Campbell L, Howard B. Progression of coronary calcification in healthy postmenopausal women. BMC Cardiovasc Disord. 2004;4:21. (Pubitemid 38923127)
48. Braun J, Oldendorf M, Moshage W, Heidler R, Zeitler E, Luft FC. Electron beam computed tomography in the evaluation of cardiac calcification in chronic dialysis patients. Am J Kidney Dis. 1996;27:394-401. (Pubitemid 26075849)
49. Kurz P, Monier-Faugere MC, Bognar B, et al. Evidence for abnormal calcium homeostasis in patients with adynamic bone disease. Kidney Int. 1994;46:855-861. (Pubitemid 24272045)
50. Dusso AS, Brown AJ, Slatopolsky E, Vitamin D. Am J Physiol Renal Physiol. 2005;289:F8-28.